Mesenchymal Stem Cells Market (By Product Type: Human MSCs, Mouse MSCs, Rat MSCs, Others; By Application: Drug discovery and development, Injuries, Cardiovascular and myocardial infarction, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Mesenchymal Stem Cells

1.1. Definition and Scope 

1.1.1. Definition of Mesenchymal Stem Cells

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Mesenchymal Stem Cells Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Mesenchymal Stem Cells Market By Product Type

1.2.3. Mesenchymal Stem Cells Market By Application

1.2.4. Mesenchymal Stem Cells Market by Regions

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restrain 1

3.2.2. Restrain 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Mesenchymal Stem Cells Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Mesenchymal Stem Cells Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2019

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019

4.2. R&D Status and Application Source of Mesenchymal Stem Cells Major Manufacturers in 2019

CHAPTER 5. Mesenchymal Stem Cells Market By Product Type

5.1. Introduction

5.2. Mesenchymal Stem Cells Revenue By Product Type

5.2.1. Mesenchymal Stem Cells Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027

5.2.2. Human MSCs

5.2.2.1. Human MSCs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.3. Mouse MSCs

5.2.3.1. Mouse MSCs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.4. Rat MSCs

5.2.4.1. Rat MSCs Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

5.2.5. Others

5.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Mesenchymal Stem Cells Market Revenue By Application

6.1. Introduction

6.2. Mesenchymal Stem Cells Revenue (US$ Mn) By Application

6.2.1. Mesenchymal Stem Cells Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

6.2.2. Drug Discovery and Development

6.2.2.1. Drug Discovery and Development Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.3. Injuries

6.2.3.1. Injuries Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.4. Cardiovascular and Myocardial Infarction

6.2.4.1. Cardiovascular and Myocardial Infarction Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.5. Toxicology Services

6.2.5.1. Toxicology Services Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

6.2.6. Others

6.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. North America Mesenchymal Stem Cells Market By Country 

7.1. North America Mesenchymal Stem Cells Overview

7.2. U.S.

7.2.1. U.S. Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

7.2.2. U.S. Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

7.3. Canada

7.3.1. Canada Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

7.3.2. Canada Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

7.4. North America PEST Analysis

CHAPTER 8. Europe Mesenchymal Stem Cells Market By Country

8.1. Europe Mesenchymal Stem Cells Market Overview

8.2. U.K.

8.2.1. U.K. Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

8.2.2. U.K. Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.3. Germany

8.3.1. Germany Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

8.3.2. Germany Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.4. France 

8.4.1. France Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

8.4.2. France Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.5. Spain

8.5.1. Spain Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

8.5.2. Spain Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.6. Rest of Europe

8.6.1. Rest of Europe Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027

8.6.2. Rest of Europe Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016-2027

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Mesenchymal Stem Cells Market By Country

9.1. Asia Pacific Mesenchymal Stem Cells Market Overview

9.2. China

9.2.1. China Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.2.2. China Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.3. Japan

9.3.1. Japan Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.3.2. Japan Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.4. India

9.4.1. India Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.4.2. India Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.5. Australia

9.5.1. Australia Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.5.2. Australia Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.6. South Korea

9.6.1. South Korea Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.6.2. South Korea Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

9.7.2. Rest of Asia-Pacific Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Mesenchymal Stem Cells Market By Country

10.1. Latin America Mesenchymal Stem Cells Market Overview

10.2. Brazil

10.2.1. Brazil Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

10.2.2. Brazil Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.3. Mexico

10.3.1. Mexico Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

10.3.2. Mexico Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

10.4. Rest of Latin America

10.4.1. Rest of Latin America Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027

10.4.2. Rest of Latin America Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Mesenchymal Stem Cells Market By Country 

11.1. Middle East & Africa Mesenchymal Stem Cells Market Overview

11.2. Saudi Arabia

11.2.1. Saudi Arabia Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

11.2.2. Saudi Arabia Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.3. UAE

11.3.1. UAE Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

11.3.2. UAE Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027

11.4.2. Rest of Middle East & Africa Mesenchymal Stem Cells Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Mesenchymal Stem Cells

12.1. Mesenchymal Stem Cells Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Mesenchymal Stem Cells Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. COMPANY PROFILE

13.1. R&D Systems, Inc.

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (US$ Mn), 2019

13.1.3.2. R&D Systems, Inc. 2019 Mesenchymal Stem Cells Business Regional Distribution

13.1.4. Product/ Service and Specification

13.1.5. Recent Developments & Business Strategy

13.1.6. Manufacturing Plant Footprint Analysis

13.2. Cell Applications, Inc.

13.3. Axol Bioscience

13.4. Cyagen Biosciences

13.5. Cytori Therapeutics, Inc.

13.6. STEMCELL Technologies Inc.

13.7. BrainStorm Cell Therapeutics Inc.

13.8. Stemedica Cell Technologies, Inc.

13.9. Celprogen, Inc.

13.10. Others

Cart Summary